This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60: 387–392
Aarsland D, Perry R, Larsen JP et al (2005) Neuroleptic sensitivity in Parkinson’s disease and Parkinsonian dementias. J Clin Psychiatry 66: 633–637
Aartsen MJ, van Tilburg T, Smits CHM et al (2005) Does widowhood affect memory performance of older persons? Psychol Med 35: 217–226
Abe K, Inokawa M, Kashiwagi A, Yanagihara T (1998) Amnesia after a discrete basal forebrain lesion. J Neurol Neurosurg Psychiatry 65: 126–130
Adlard PA, Cummings BJ (2004) Alzheimer’s disease — a sum greater than its parts? Neurobiol Aging 25(6): 725–733
Adler G, Teufel M, Drach LM (2003) Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide. Int J Geriatr Psychiatry 18: 653–655
Adler G, Brassen S, Chwalek K et al (2004) Prediction of treatment response to rivastigmine in Alzheimer’s dementia. J Neurol Neurosurg Psychiatry 75: 292–294
Alafuzoff I, Overmeyer M, Helisalmi S, Soninen H (2000) Lower counts of astroglia and activated microglia in patients with Alzheimer’s disease with regular use of non-steroidal anti-inflammatory drugs. J Alzheimer Dis 2: 37–46
Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13: 266–271
Alvarez G, Munoz-Montano JR, Satrustegui J et al (1999) Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett 453: 260–264
Alzheimer A (1898) Neuere Arbeiten über die Dementia senilis und die auf atheromatöser Gefässerkrankung basierenden Gehirnkrankheiten. Monatsschr Psychiat Neurol 3: 101–115
Alzheimer A (1899) Beitrag zur pathologischen Anatomie der Seelenstörungen des Greisenalters. Neurol Centralbl 18: 95–96
Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Z Ges Neurol Psychiatrie 4: 356–385
Anttila T, Helkala E-L, Viitanen M et al (2004) Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. Br Med J 329: 539
Arendt T (2004) Neurodegeneration and plasticity. Int J Dev Neurosci 22: 507–514
Arnulf I, Konofal E, Merino-Andreu M et al (2002) Parkinson’s disease and sleepiness. Neurology 58: 1019–1024
Ashford JW, Shih WJ, Coupal J et al (2000) Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer’s disease. J Nucl Med 41: 57–64
Ashworth A, Lloyd S, Brown J et al (1999) Molecular genetic characterisation of frontotemporal dementia on chromosome 3. Dement Geriatr Cogn Disord 10: 93–101
Atkinson RC, Shiffrin RM (1968) Human memory: a proposed system and its control processes. In: Spence KW (ed) The psychology of learning and motivation, vol 2. Academic Press, New York, pp 89–195
Baars BJ, Ramsoy TZ, Laureys S (2003) Brain, conscious experience and the observing self. Trends Neurosci 26: 671–675
Bacon AW, Bondi MW, Salmon DP, Murphy C (1998) Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855: 723–731
Baddeley AD, Hitch G (1974) Working memory. In: Bower GA (ed) The psychology of learning and motivation, vol 8. Academic Press, New York, pp 47–89
Bailey CH, Kandel ER (2004) The persistence of long-term memory: a molecular approach to self-sustaining changes in learning-induced synaptic growth. Neuron 30(44): 49–57
Ballard C, Piggott M, Johnson M et al (2000) Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 48: 868–876
Ballard CG, Aarsland D, McKeith I et al (2002) Fluctuations in attention. Neurology 59: 1714–1720
Barco A, Pittenger C, Kandel ER (2003) CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets 7: 101–114
Bartels C (2005) Demenz bei degenerativen Systemerkrankungen. In: Wallesch CW, Förstl H (Hrsg) Demenzen. Thieme, Stuttgart, S 195–209
Bäzner H, Daffertshofer M, Hennerici M (2003) Subkortikale vaskuläre Enzephalopathie. Aktuelle Neurol 30: 266–280
Berger G, Bernhardt T, Schramm U et al (2004) No effects of a combination of caregivers support group and memory training/music therapy in dementia patients from a memory clinic population. Int J Geriatr Psychiatry 19(3): 223–231
Bertram L, Tanzi R (2004) Alzheimer’s disease: one disorder, too many genes? Hum Mol Genet 13: R135–R141
Bertram L, Tanzi R (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115(6): 1449–1457
Bickel H, Gradinger R, Kochs E et al (2004) Inzidenz und Risikofaktoren eines Delirs nach Hüftgelenkoperation. Psychiat Praxis 301: 360–365
Bird T, Knopman D, VanSwieten J et al (2003) Epidemiology and genetics of frontotemporal dementia/Pick’s disease. Ann Neurol 54(Suppl 5): 29–31
Birge SJ, McEwen BS, Wise PM (2001) Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women. Postgrad Med Spec No 11–16
Blanchard BJ, Konopka G, Russell M, Ingram VM (1997) Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer’s disease. Brain Res 776: 40–50
Blasko I, Grubeck-Loebenstein B (2003) Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s disease. Drugs Aging 20: 101–113
Bobinski M, De Leon MJ, Convit A, De Santi S (1999) MRI of entorhinal cortex in mild Alzheimer’s disease. Lancet 353: 38–40
Bobinski M, De Leon MJ, Weigel J (2000) The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer’s disease. Neurosci 95: 721–725
Boeve BF, Silber MH, Parisi JE et al (2003) Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61: 40–45
Bohnen NI, Kaufer DI, Ivanco LS et al (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia. Arch Neurol 60: 1745–1748
Boly M, Faymonville ME, Peigneux P et al (2004) Auditory processing in severely brain injured patients. Arch Neurol 61: 233–238
Bonhoeffer K (1912) Die Psychosen im Gefolge von akuten Infektionen, Allgemeinerkrankungen und inneren Erkrankungen. In: Aschaffenburg G (Hrsg) Handbuch der Psychiatrie. Spezieller Teil, 3. Abt, 1. Hälfte. Franz Deuticke, Leipzig Wien, S 106–107
Bookheimer SY, Strojwas MH, Cohen MS et al (2000) Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 343: 450–456
Borroni B, Agosti C, Brambilla C et al (2004) Is transient global amnesia a risk factor for amnestic mild cognitive impairment? J Neurol 251: 1125–1127
Bosch J, Yusuf S, Pogue J et al, on behalf of the HOPE Investigators (2002) Use of ramipril in preventing stroke: double blind randomised trial. BMJ 324: 1–5
Bogousslavsky J, Kaplan L (eds) (1995) Stroke syndromes. Cambridge University Press, Cambridge, MA
Bozeat S, Gregory CA, Lambon MA et al (2000) Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease? J Neurol Neurosurg Psychiatry 69: 178–186
Braak E, Arai K, Braak H (1999) Cerebellar involvement in Pick’s disease: Affliction of mossy fibers, monodendritic brush cells, and dentate projection neurons. Exp Neurol 159: 153–163
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259
Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 92: 197–201
Braak H, Braak E (1998) Involvement of precerebellar nuclei in Pick’s disease. Exp Neurol 153: 351–365
Braak H, Tredici KD, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211
Branchimonte M, Einstein GO, McDaniel MA (1996) Prospective memory: Theory and applications. Lawrence Erlbaum, Mahwah, NJ
Breitbart W, Gibson C, Tremblay A (2002) The delirium experience. Psychosomatics 43: 183–194
Breitner JCS, Welsh KA, Helms MJ et al (1995) Delayed onset of Alzheimer’s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 16: 523–530
Brettschneider S, Morgenthaler NG, Teipel SJ et al (2005) Decreased serum amyloid β1-42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide. Biol Psychiatry 57: 813–816
Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60: 1005–1011
Burn DJ, O’Brien JT (2003) Use of functional imaging in parkinsonism and dementia. Mov Disord 18: S88–S95
Burruss JW, Hurley RA, Taber KH et al (2000) Functional neuroanatomy of the frontal lobe circuits. Radiology 214: 227–230
Burton E, Ballard C, Stephens S et al (2003) Hyperintensities and frontosubcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dement Geriatr Cogn Disord 16: 113–118
Busse A, Bischkopf J, Riedel-Heller SG et al (2002) Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand 108: 71–81
Busse A, Bischkopf J, Riedel-Heller SG et al (2003) Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med 33: 1029–1038
Butterfield DA, Pocernich CB (2003) The glutametergic system and Alzheimer’s disease. CNS Drugs 17: 641–652
Casserly I, Topol E (2004) Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363: 1139–1146
Caeiro L, Menger C, Ferro JM, Albuquerque R, Figueira ML (2005) Delirium in acute subarachnoid haemorrhage. Cerebrovasc Dis 19: 31–38
Campion D, Dumanchin C, Hannequin D et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogenity, and mutation spectrum. Am J Hum Genet 65: 664–670
Caplan LR (1985) Transient global amnesia. Elsevier, Amsterdam
Celsis P (2000) Age-related cognitive decline, mild cognitive impairment, or preclinical Alzheimer’s disease. Ann Med 32: 6–14
Centonze D, Gubellini P, Pisani A et al (2003) Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci 14: 207–216
Chan D, Fox NC, Jenkins R (2001a) Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology 57: 1756–1763
Chan D, Fox NC, Scahill R et al (2001b) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol 49: 433–442
Chan D, Janssen JC, Whitwell JL et al (2003) Change in rates of cerebral atrophy over time in early-onset Alzheimer’s disease: longitudinal MRI study. Lancet 362: 1121–1122
Chen RW, Chuang DM (1999) Long-term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuropretection against excitotoxicity. J Biol Chem 274: 6039–6042
Chen CP, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM (2000a) Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer’s disease assessed for behavioural change. Neuropathol Appl Neurobiol 26: 347–355
Chen G, Rajkowska G, Du F et al (2000b) Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75: 1729–1734
Chen P, Ratcliff G, Belle SH et al (2000c) Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55: 1847–1853
Chetelat G, Eustache F, Viader F et al (2005) FDG-PET measurement is more accurate than neurospsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 11(1): 14–25
Chodosh J, Reuben DB, Albert MS et al (2002) Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 50: 1051–1060
Chow TW, Mendez MF (2002) Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration, Am J Alzheimer Dis Oth Dem 17: 267–272
Chow TW, Miller BL, Hayashi VN et al (1999) Inheritance of frontotemporal dementia. Arch Neurol 56: 817–822
Chung JC, Lai CK, Chung PM et al (2002) Snoezelen for dementia. Cochrane Database Syst Rev 4: CD003152
Clark CM, Karlawish JHT (2003) Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med 138: 400–410
Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL (1992) The time course of glutamate in the synaptic cleft. Science 258: 1498–1501
Coffey CE, Saxton JA, Ratcliff G, Bryan RN, Lucke JF (1999) Relation of education to brain size in normal aging: implications for the reserve hypothesis. Neurology 53: 189–196
Cohen N, Squire L (1980) Preserved learning and retention of patterns analysing skills in amnesia: dissociation of knowing how from knowing that. Science 210: 207–210
Colangelo V, Schurr J, Balll MJ et al (2002) Gene expression profiling of 12.633 genes in Alzheimer hippocampal CA1: down-regulation and up-regulation of apoptotic and pro-inflammatory signalling. J Neurosci Res 70: 462–473
Collerton D, Burn D, McKeith I, O’Brien J (2003) Systematic review and meta-analysis show that dementia with Lewy bodies is a visualperceptual and attentional-executive dementia. Dement Geriatr Cogn Disord 16: 229–237
Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease (1997) The National Institute of Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging 18(Suppl 4): 1–2
Cools R, Stefanova E, Barker RA et al (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 125: 584–594
Cordoliani-Mackowiak M-A, Henon H, Pruvo J-P, Pasquier F, Leys D (2003) Poststroke dementia — influence of hippocampal atrophy. Arch Neurol 60: 585–590
Cruts M, van Duijin CM, Backhovens H et al (1998) Estimation of the genetic contribution of presenilin-1 and-2 mutations in a population based study of presenile Alzheimer disease. Hum Mol Genet 7: 43–51
Davis KL, Mohs RC, Marin DB et al (1999) Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry 56: 981–987
de la Torre J (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurology 3: 184–190
Dekker MC, Bonifati V, van Duijn CM (2003) Parkinson’s disease — piecing together a genetic jigsaw. Brain 126: 1722–1733
DeKosky ST, Ikonomovic MD, Styren SD et al (2002) Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 51: 145–155
del Ser T, Hachinski V, Merskey H, Munoz DG (1999) An autopsy-verified study of the effect of education on degenerative dementia. Brain 1222: 2309–2319
Dermaut P, Kumar-Singh S, Engelborghs S et al (2004) A novel presenilin 1 mutation associated with Pick’s desease but not beta-amyloid plaques. Ann Neurol 55: 617–626
Desgranges B, Baron JC, De La Sayette V et al (1998) The neural substrates of memory systems impairment in Alzheimer’s disease. A PET study of resting brain glucose utilization. Brain 121: 611–631
Devinsky O (1992) Behavioral Neurology. Arnold, London
Di Napoli M, Schwaninger M, Cappelli R et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36(6): 1316–1329
Diehl J, Grimmer T, Drzezga A (2004) Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 25: 1051–1056
Diehl J, Monsch AU, Aebi C et al (2005) Frontotemporal dementia, semantic dementia, and Alzheimer’s disease: the contribution of standard neuropsychological tests to differential diagnosis. J Geriatr Psychiatry Neurol 18: 39–44
Dodel RC, Du Y, Bales KR et al (2000) a-2 macroglobulin and the risk of Alzheimer’s disease. Neurology 54: 438–445
Drzezga A, Grimmer T, Siebner H, Minoshima S, Schwaiger M, Kurz A (2002) Prominent hypometabolism of the right tempoparietal and frontal cortex in two left-handed patients with primary progressive aphasia. J Neurol 249: 1263–1267
Dubois B, Albert ML (2004) Amnestic MCI or prodromal Alzheimer’s disease. Lancet Neurology 3: 246–248
Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The frontal assessment battery at bedside. Neurology 55: 1621–1626
Duda JE (2004) Pathology and neurotransmitter abnormalities of dementia with Lewy bodies. Dement Geriatr Cogn Disord 17: 3–14
Duda JE, Giasson BI, Mabon ME et al (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52: 205–210
Eikelenboom P, Rozenmuller JM, van Muiswinkel FL (1998) Inflammation and Alzheimer’s disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154: 89–98
Elias MF, Wolf PA, D’Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 138: 353–364
Emre M, Aarsland D, Albanese A et al (2004) Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 351: 2509–2518
Engelhart MJ, Geerlings MI, Ruitenberg A et al (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Ass 287: 3223–3229
Enz A, Gentsch C (2004) Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain. Neuropharmacology 47: 408–413
Eriksen JL, Sagi SA, Smith TE et al (2003a) NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo. J Clin Invest 112: 440–449
Eriksen, JL, Dawson TM, Dickson TW, Petrucelli L (2003b) Caught in the act: alpha-synuclein is the culprit in Parkinson’s disease. Neuron 40: 453–456
Etminan M, Gill S, Samii A (2003) Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer’s disease: systematic review and meta-analysis of observational studies. Br Med J 327: 128
Eustache F, Desgranges B, Laville P et al (1999) Episodic memory in transient global amnesia: encoding, storage, or retrieval deficit? J Neurol Neurosurg Psychiatry 66: 154
Farah MJ, Illes J, Cook-Deegan R et al (2004) Neurocognitive enhancement: what can we do and what should we do? Nature Neurosci 5: 421–425
Fein G, DiSclafani V, Tanabe J et al (2000) Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55: 1626–1635
Fellgiebel A, Scheurich A, Siessmeier T, Schmidt LG, Bartenstein P (2003) Persistence of disturbed thalamic glucose metabolism in a case of Wernicke-Korsakow syndrome. Psychiatry Res Neuroimaging 124: 105–112
Fernando MS, Ince PG, MRC Cognitive Function and Ageing Neuropathology Study Group (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226: 13–17
Fischer P, Assem-Hilger E (2003) Delir/Verwirrtheitszustände. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie &-psychotherapie. Thieme, Stuttgart
Flechsig P (1927) Meine myelogenetische Hirnlehre. Julius Springer, Berlin
Forbes D, Morgan D, Bangma J et al (2004) Therapy for managing sleep, behaviour, and mood disturbances in dementia. Cochrane Database Syst Rev 2: CD003946
Ford JM, Askari N, Mathalon DH et al (2001) Event-related brain potential evidence of spared knowledge in Alzheimer’s disease. Psychol Aging 16. 161–176
Forette F, Seux ML, Staessen JA et al, on behalf of the Syst-Eur Investigators (1998) Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352: 1347–1351
Forette F, Seux ML, Staessen JA et al, for the Syst-Eur Investigators (2002) The prevention of dementia with antihypertensive treatment. New evidence from the sytolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 162: 2046–2052
Förstl H (2004) Neurodegenerative und verwandte Erkrankungen. In: Förstl H (Hrsg) Frontalhirn — Funktionen und Erkrankungen, 2. Aufl. Springer, Berlin Heidelberg New York, S 144–175
Förstl H, Besthorn C, Hentschel F et al (1996) Frontal lobe degeneration and Alzheimer’s disease: A controlled study on clinical findings, volumetric brain changes and quantitative electroencephalography data. Dementia 7: 27–34
Förstl H, Burns A, Zerfass R (2003) Alzheimer Demenz — Diagnose, Symptome und Verlauf. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie und-psychotherapie. Thieme, Stuttgart, S 324–345
Fox NC, Schott JM (2004) Imaging cerebral atrophy: normal ageing to Alzheimer’s disease. Lancet 363: 392–394
Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer’s disease. Lancet 353: 2125
Francis PT (2003) Glutamatergic systems in Alzheimer’s disease. Int J Geriatr Psychiatry 18: 15–21
Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: a communitybased longitudinal study. Lancet 355: 1315–1319
Gainotti G, Barbier A, Marra C (2003) Slowly progressive defect in recognition of familiar people in a patient with right anterior temporal atrophy. Brain 126: 793–803
Gallinat J, Moller HJ, Hegerl U (1999) Piracetam in anesthesia for prevention of postoperative delirium. Anasthesiol Intensivmed Notfallmed Schmerzther 34: 520–527
Galton CJ, Gomez-Anson B, Antoun N (2001) Temporal lobe rating scale: application to Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 70: 165–173
Garrard P, Hodges JR (2000) Semantic dementia: clinical, radiological and pathological perspectives. J Neurol 247: 409–422
Geerts H (2004) NC-531 (Neurochem). Curr Opin Investig Drugs 5: 95–100
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33–39
Giacino JT, Ashwal S, Childs N et al (2002) The minimally conscious state. Definition and diagnostic criteria. Neurology 58: 349–353
Giladi N, Shabtai H, Gurevich T et al (2003) Rivastigmine (Exelon) for dementia in patients with Parkinson’s disease. Acta Neurol Scand 108: 368–373
Gill SS, Rochon PA, Herrmann N et al (2005) Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. Br Med J 330(7489): 445
Gislason TB, Sjögren M, Larsson L, Skoog I (2003) The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J Neurol Neurosurg Psychiatry 74: 867–871
Godbolt AK, Josephs KA, Revesz T (2005) Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 62: 1097–1101
Goedert M, Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739: 240–250
Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau. Sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3: 519–526
Goldman WP, Price JL, Storandt M et al (2001) Absence of cognitive impairment or decline in preclinical Alzheimer’s disease. Neurology 56: 361–367
Gómez-Tortosa E, Gonzalo I, Fanjul S et al (2003) Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease. Arch Neurol 60: 1218–1222
Gorwood P, Limosin F, Batel P et al (2003) The a9 allele of the dopamine transporter gene in associated with delirium tremens and alcoholwithdrawal seizure. Biol Psychiatry 53: 85–92
Gosche KM, Mortimer JA, Smith CD et al (2002) Hippocampal volume as an index of Alzheimer neuropathology. Neurology 58: 1476–1482
Graf P, Schacter DL (1985) Implicit and explicit memory for new associations in normal subjects and amnesic patients. J Exp Psychol Learn Mem Cogn 11: 501–518
Gregory CA, Lough S, Stone V et al (2002) Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer’s disease: theoretical and practical implications. Brain 125: 752–764
Grimaldi LM, Casadei VM, Ferri C et al (2000) Association of early-onset Alzheimer’s disease with an interleukin-I-alpha gene polymorphism. Ann Neurol 47: 361–365
Grimmer T, Diehl J, Drzezga A (2004) Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study. Dement Geriatr Cogn Disord 18: 32–36
Grober E, Lipton RB, Hall C et al (2000) Memory impairment on free and cued selective reminding predicts dementia. Neurology 54: 827–832
Groenewegen HJ, Wright CI, Uylings HBM (1997) The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia. J Psychopharmacol 11: 99–106
Gsell W, Jungkunz G, Riederer P (2004) Functional neurochemistry of Alzheimer’s disease. Curr Pharm Design 10: 265–293
Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M (1999) Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 56: 991–996
Gustafson D, Rothenberg E, Blennow K, Stehen B, Skoog I (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163: 1524–1528
Haberl RL, Schreiber AK (2001) Binswanger und andere vaskuläre Demenzen. In: Förstl H (Hrsg) Demenzen in Theorie und Praxis. Springer, Berlin Heidelberg New York, S 63–82
Hajjar I, Schumpert J, Hirth V, Wieland D, Eleazer GP (2002) The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol A Biol Sci Med Sci 57: M414–418
Hamann J, Liebetrau M (2002) Demenz bei zerebrovaskulären Erkrankungen. In: Beyreuther K, Einhäupl KM, Förstl H, Kurz A (Hrsg) Demenzen — Grundlagen und Klinik. Thieme, Stuttgart, S 221–244
Hamann J, Bickel H, Schwaibold H et al (2005) Postoperative confusional state in typical urologic population: incidence, risk factors, and strategies for prevention. Urology 65: 449–453
Hampel H, Bürger K, Pruessner JC et al (2005) Correlation of cerebrospinal fluid levels of tau phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer’s disease. Arch Neurol 62: 770–773
Hashimoto M, Kazui H, Matsumoto K et al (2005) Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer’s disease? Am J Psychiatry 162: 676–682
Hassan A, Hunt BJ, O’Sullivan M et al (2003) Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127: 212–219
Haupt WF, Rudolf J (1999) European brain death codes: a comparison of national guidelines. J Neurol 246: 432–437
Healy DG, Abou Sleiman PM, Wood NW (2004) PINK, PANK or PARK? A clinicians’ guide to familial Parkinsonism. Lancet Neurology 3: 652–656
Hebb DO (1949) The organization of behavior. A neuropsychological theory. Wiley, Chichester
Hénon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D (2001) Poststroke dementia — incidence and relationship to prestroke cognitive decline. Neurology 57: 1216–1222
Herrmann N, Mamdani M, Lanctot KL (2004) Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161: 1113–1115
Hirono N, Mori E, Ishii K et al (2001) Neuronal substrates for semantic memory: a positron emission tomography study in Alzheimer’s disease. Dement Geriatr Cogn Disord 12: 15–21
Hock C, Konietzko U, Streffer JR et al (2003) Antibodies against betaamyloid slow cognitive decline in Alzheimer’s disease. Neuron 38: 547–554
Hodges JR (2001) Frontotemporal dementia (Pick’s disease): Clinical features and assessment. Neurology 56(Suppl 4): S6–S10
Hodges JR, Warlow CP (1990a) Syndromes of transient amnesia: towards a classification: a study of 153 cases. J Neurol Neurosurg Psychiatry 53: 834–843
Hudges JR, Warlow CP (1990b) The aetiology of transient global amnesia: a case-control study of 114 cases with prospective follow-up. Brain 113: 639–657
Hodges JR, Davies RR, Xuereb JH et al (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56: 399–406
Hofman A, Ott A, Breteler MMB et al (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349: 151–154
Honig LS, Kukull W, Mayeux R (2005) Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology 64: 494–500
Howell O, Atack JR, Dewar D, McKernan RM, Sur C (2000) Densitiy and pharmacology of α5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer’s disease patients. Neuroscience 98: 669–675
Huang YY, Pittenger C, Kandel ER (2004) A form of long-lasting, learning-related synaptic plasticity in the hippocampus induced by heterosynaptic low-frequency pairing. Proc Natl Acad Sci USA 101: 859–864
Hutton M, Lendon C, Rizzu P et al (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702–705
Hyman BT, van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168–1170
Hyman BT, van Hoesen GW, Damasio AR (1990) Memory-related neural systems in Alzheimer’s disease: an anatomic study. Neurology 40: 1721–1730
Hyman BT, Augustinack JC, Ingelsson M (2005) Transcriptional and conformational changes of the tau molecule in Alzheimer’s disease. Biochim Biophys Acta 1739: 150–157
Ibach B (2005) Frontotemporale Demenzen (mit ALS-Komplex). In: Wallesch CW, Förstl H (Hrsg) Demenzen. Thieme, Stuttgart, S 180–195
Ibach B, Koch H, Koller M et al (2003) Hospital admission circumstances and prevalence of frontotemporal lobar degeneration: a multicenter psychiatric state hospital study in Germany. Dement Geriatr Cogn Disord 16: 253–264
Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR (2002) Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 73: 371–376
Ikeda M, Shigenobu K, Fukuhara R (2004) Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord 17: 117–121
Ingrosso D, Cimmino A, Perna AF et al (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361: 1693–1698
Inouye S, Bogardus ST, Charpentier PA et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340: 669–676
in’t Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM (2001) Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22: 407–412
Jacobs DM, Heberlein I, Vieregge A et al (2001) Personality traits in young patients with Parkinson’s disease. Acta Neurol Scand 103: 82–87
Jahn T (2004) Neuropsychologie der Demenz. In: Lautenbacher S, Gauggel S (Hrsg) Neuropsychologie psychischer Störungen. Springer, Berlin Heidelberg New York, S 301–338
James W (1890/1950) The principles of psychology, chap IX: The stream of thought. Dover Publications, New York, pp 246–248
Johnson JK, Diehl J, Mendez MF et al (2005) Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 62(6): 925–930
Jones C, Griffiths RD, Humphris G (2000) Disturbed memory and amnesia related to intensive care. Curr Surg 8: 79–94
Jorm AF, Christensen H, Korten AE et al (2001) Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis. Psychol Med 31: 441–449
Jorm AF, Masaki KH, Petrovitch H et al (2005) Cognitive deficits 3 to 6 years before dementia onset in a population sample: the Honolulu-Asia aging study. J Am Geriatr Soc 53(3): 452–455
Joyce JN, Myers AJ, Gurevich E (1998) Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer’s disease. Brain Res 784: 7–17
Jungwirth S, Weissgram S, Zehetmayer S et al (2005) VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Int J Geriatr Psychiatry 20: 452–458
Kado DM, Karlamangla AS, Huang MH et al (2005) Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitve function and decline in older high-functioning adults: Mac Arthur Studies of Successful Aging. Am J Med 118: 161–167
Kalbe E, Salmon E, Perani D et al (2005) Anosognosia in very mild Alzheimer’s disease but not in mild cognitive impairment. Dement Geriatr Cogn Disord 19(5–6): 349–356
Kantarci K, Petersen RC, Boeve BF et al (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64(5): 902–904
Kaplan PW (2004) The EEG in metabolic encephalopathy and coma. J Clin Neurophysiol 21: 307–318
Kay G, Pollack BG, Romanzi LJ (2004) Unmasking anticholinergic load: when 1 + 1 = 3. CNS Spectr 9(12 Suppl 15): 1–11
Kazui H, Matsuda A., Hirono N et al (2005) Everyday memory impairment of patients with mild cognitive impairment. Dement Geriatr Cogn Disord 19(5–6): 331–337
Kelly PJ, Rosand J, Kistler JP et al (2002) Homocysteine, MTHFR 677C — T polymorphism, and risk of ischemic stroke, results of a meta-analysis. Neurology 59: 529–536
Kessler H, Bleich S, Falkai P, Supprian T (2003) Homozystein und Demenzerkrankungen. Fortschr Neurol Psychiat 71: 150–156
Kilander L, Nyman H, Boberg M, Hansson L, Lithell H (1998) Hypertension is related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension 31: 780–786
Kim EJ, Buschmann MT (1999) The effect of expressive physical touch on patients with dementia. Int J Nurs Stud 36: 235–243
Kivipelto M, Helkala E-L, Laakso M et al (2001) Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, polulation based study. Br Med J 322: 1447–1451
Klegeris A, McGeer PL (2005) Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res 2: 355–365
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455–8459
Klyubin I, Walsh DM, Lemere CA et al (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nature Med 11: 556–561
Knecht S, Berger A (2004) Einfluss vaskulärer Faktoren auf die Entwicklung einer Demenz. Dtsch Ärztebl 101: C1760–C1764
Kogure D, Matsuda H, Ohnishi T et al (2000) Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. J Nucl Med 41: 1155–1162
Kordower JH, Chu Y, Stebbins GT et al (2001) Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 49:202–213
Korf ES, White LR, Scheltens P, Launer LJ (2004) Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 44: 29–34
Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41: 135–144
Kotchoubey B, Lang S, Bostanov V, Birbaumer N (2002) Is there a mind? Electrophysiology of unconscious patients. News Physiol Sci 17: 38–42
Kril JJ, Patel S, Harding AJ, Halliday GM (2002) Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 72: 747–751
Kumar R, Dear KB, Christensen H et al (2005) Prevalence of mild cognitive impairment in 60-64-year-old community-dwelling individuals: The Personality and Total Health through Life 60+ Study. Dement Geriatr Cogn Disord 19(2–3): 67–74
Kurz A (2002) Klinik der Alzheimer Demenz. In: Beyreuther K, Einhäupl KM, Förstl H, Kurz A (Hrsg) Demenzen — Grundlagen und Klinik. Thieme, Stuttgart, S 168–186
Lai MKP, Tsang SWY, Francis PT et al (2003) Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 974: 82–87
Larrieu S, Letenneur L, Orgogozo JM et al (2002) Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59: 1594–1599
Lashley KS (1929) Brain mechanisms and intelligence. University of Chicago Press, Chicago
Launer LJ (2005) The epidemiologic study of dementia: a life-long quest? Neurobiol Aging 26: 335–340
Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ (1995) The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. J Am Med Ass 274: 1846–1851
Laureys S, Goldman S, Phillips C et al (1999) Impaired effective cortical connectivity in vegetative state: Preliminary investigation using PET. NeuroImage 9: 377–382
Laureys S, Owen AM, Schiff ND (2004) Brain function in coma, vegetative state, and related disorders. Lancet Neurology 3: 537–546
Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58: 498–504
Lautenschlager NT, Cupples LA, Rao VS et al (1996) Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE study: what is in store for the oldest old? Neurology 46: 641–659
Lautenschlager NT, Riemenschneider M, Drzezga A et al (2001) Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord 12: 379–386
Lavie N (2005) Distracted and confused: Selective attention under load. Trends Cogn Sci 9: 75–82
Laws SM, Clarnette RM, Taddei K et al (2002) APOE-ε4 and APOE-491A polymorphisms in individuals with subjective memory loss. Mol Psychiatry 7: 768–775
le Carret N, Lafont S, Mayo W, Fabrigoule C (2003) The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve. Dev Neuropsychol 23: 317–337
LeBlanc ES, Janowsky J, Chan BK, Nelson HD (2001) Hormone replacement therapy and cognition: systematic review and meta-analysis. J Am Med Ass 285: 1489–1499
Leisman G, Koch P (2003) Synaptic strengthening and continuum activity-wave growth in temporal sequencing during cognitive tasks. Int J Neurosci 113: 181–204
Lemere CA, Spooner ET, Leverone JF et al (2003) Amyloid-beta immunization in Alzheimer’s disease transgenic mouse models and wildtype mice. Neurochem Res 28: 1017–1027
Lemke MR, Ceballos-Baumann AO (2002) Depression bei Parkinson-Patienten. Dtsch Ärztebl 99: C2100–C2104
Leung BP, Sattar N, Crilly A et al (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 170: 1524–1530
Lewy FH (1913) Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 50: 50–55
Lewy FH (1923) Die Lehre vom Tonus und von der Bewegung. Zugleich systematische Untersuchung zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis agitans. Springer, Berlin
Lezoualc’h F, Robert SJ (2003) The serotonin 5-HT4 receptor and the amyloid precursor protein processing. Exp Gerontol 38: 159–166
Lindsay J, Laurin D, Verreault R et al (2002) Risk factors for Alzheimer’s disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156: 445–453
Lipowski ZJ (1990) Delirium-acute confusional states. Oxford University Press, Oxford
Lithell H, Hansson L, Skoog I et al, for the SCOPE Study Group (2003) The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind interventional trial. Hypertension 21: 875–886
Litvan I (2001) Therapy and management of frontal lobe dementia patients. Neurology 56(Suppl 4): S41–S45
Lobotesis K, Fenwick JD, Phipps A et al (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56: 643–649
Londos E, Passant U, Gustafson L et al (2001) Neuropathological correlates to clinically defined dementia with Lewy bodies. Int J Geriatr Psychiatry 16: 667–679
Lopez OL, Becker JT, Sweet RA (2005) Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase 11(1): 65–71
Lough S, Hodges JR (2002) Measuring and modifying abnormal social cognition in frontal variant frontotemporal dementia. J Psychosom Res 53: 639–646
Machulda MM, Ward HA, Borowski B et al (2003) Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. Neurology 61: 500–506
Magoun H (1958) The waking brain. Thomas, Springfield, p 70, Fig 32, pp 115–116
Maia L, de Mendonca A (2002) Does coffeine intake protect from Alzheimer’s disease? Eur J Neurol 9: 377–382
Maidment ID, Fox C, Boustani M (2005) A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson’s disease dementia. Acta Psychiatr Scand 111: 403–409
Mann DM, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56: 605–614
Markowitsch HJ (1998) The mnestic block syndrome: Environmentally induced amnesia. Neurol Psychiatry Brain Res 6: 73–80
Markowitsch HJ (2003) Psychogenic amnesia. Neuroimage 20: S132–S138S
Markowitsch HJ, Calabrese P (2003) Neuropsychologie des Gedächtnisses. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie &-psychotherapie. Thieme, Stuttgart, S 75–86
Marquis S, Moore MM, Howieson DB et al (2002) Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 59:601–606
Martin PR, Singleton CK, Hiller-Sturmhöfel S (2003) The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 27: 134–142
Mato JM, Lu SC (2005) Homocysteine, the bad thiol. Hepatology 41: 976–979
Mattson MP, Guo ZH, Geiger JD (1999) Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem 73: 532–537
McCurry SM, Gibbons LE, Logsdon RG et al (2005) Nighttime insomnia treatment and education for Alzeimer’s disease: a randomized, controlled trial. J Am Geriatr Soc 53: 793–802
McKeith I, Mintzer J, Aarsland D et al (2004a) Dementia with Lewy bodies. Lancet Neurology 3: 19–28
McKeith IG, Wesnes KA, Perry E, Ferrara R (2004b) Hallucinations predict attentional improvements with rivastigmine in dementia with Lewy bodies. Dement Geriatr Cogn Disord 18: 94–100
McKhann GM, Albert MS, Grossman M et al (2001) Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 58: 1803–1809
McKhann GM, Grega MA, Borowicz LM et al (2002) Encephalopathy and stroke after coronary artery bypass grafting. Arch Neurol 59: 1422–1428
Mega MS, Cummings JL (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6: 358–370
Mesulam MM (1990) Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 28: 597–613
Mesulam MM (1996) The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer’s disease. Prog Brain Res 109: 285–297
Mesulam MM (2001) Primary progressive aphasia. Ann Neurol 49: 425–432
Mileusnic R, Lancashire CL, Johnston ANB, Rose SPR (2000) APP is required during an early phase of memory formation. Eur J Neurosci 12: 4487–4495
Miller JW, Selhub J, Nadeau MR et al (2003) Effect of L-dopa on plasma homocysteine in PD patients. Neurology 60: 1125–1129
Minoshima S, Foster NL, Sima AAF et al (2001) Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50: 358–365
Minoshima S, Frey KA, Cross DJ, Kuhl DE (2004) Neurochemical imaging of dementias. Semin Nucl Med 34: 70–82
Mintzer J, Brawman-Mintzer O, Mirski DF et al (1998) Fenluramine challenge test as a marker of serotonin activity in patients with Alzheimer’s dementia and agitation. Biol Psychiatry 44: 918–921
Mirenowicz J, Schultz W (1996) Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379: 449–451
Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry of Alzheimer’s Disease (CERAD), Part II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41: 479–486
Mitchell TW, Mufson EJ, Schneider JA et al (2002) Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer’s disease. Ann Neurol 51: 182–189
Modrego PJ, Fayed N, Pina MA (2005) Conversion from mild cognitive impairment to probable Alzheimer’s disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 162(4): 667–675
Montgomery P, Dennis J (2004) A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 8(1): 47–62
Moretti R, Torre P, Antonello RM et al (2003) Frontotemporal dementia: paroxetine as a possible treatment of behaviour symptoms. A randomized, controlled, open 14-month study. Eur Neurol 49(1): 13–19
Morris MC, Evans DA, Bienias JL et al (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60: 194–200
Mufson EJ, Ikonomovic MD, Styren SD et al (2003) Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol 60: 1143–1148
Müller T (2005) Neurodegenerative Prozesse mit extrapyramidalen und dementiellen Symptomen. In: Förstl H (Hrsg) Demenzen — Perspektiven in Forschung und Praxis. Urban & Fischer, München, S 143–152
Mungas D, Reed BR, Ellis WG, Jagust WJ (2001) The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 58: 1243–1247
Munoz DG, Dickson DW, Bergeron C et al (2003) The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 54(Suppl 5): 24–28
Munro C Saxton J, Butters MA (2001) Alcohol dementia: »cortical« or »subcortical« dementia? Arch Clin Neurosychol 16(6): 523–533
Murphy C (1999) Loss of olfactory function in dementing disease. Physiol Behav 66: 177–182
Neal M, Briggs M (2003) Validation therapy for dementia. Cochrane Database Syst Rev (3): CD001394
Neary D, Snowden JS, Northen B et al (1988) Dementia of frontal lobe type. J Neurol Neurosurg 51: 353–361
Nestor PJ, Fryer TD, Smielewski P et al (2003a) Limbic hypometabolism in Alzheimer’s disease and mild cognitive impairment. Ann Neurol 54: 343–351
Nestor PJ, Graham NL, Fryer TD et al (2003b) Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126: 2406–2418
Nicholl DJ, Greenstone MA, Clark CE (2003) An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 54: 682–686
Nilsson K, Gustafson L, Hultberg B (2001) Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 16: 609–614
Nitsch RM, Kim C, Growdon JH (1998) Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer’s disease. Neurochem Res 23: 807–814
Nonaka S, Chuang DM (1998) Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 9: 2081–2084
Nonaka S, Hough CJ, Chuang DM (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 95: 2642–2647
Nordberg A (1996) Pharmacological treatment of cognitive dysfunction in dementia disorders. Acta Neurol Scand 168: 87–92
Odawara T, Shiozaki K, Iseki E, Hino H, Kosaka K (2003) Alterations of muscarinic acetylcholine receptors in atypical Pick’s disease without Pick bodies. J Neurol Neurosurg Psychiatry 74: 965–967
Ostrosky-Solis F, Castaneda M, Perez M, Castillo G, Bobes MA (1998) Cognitive brain activity in Alzheimer’s disease: electrophysiological response during picture semantic categorization. J Int Neuropsychol Soc 4: 415–425
Oswald WD, Hagen B, Rupprecht R (2001) Die SIMA-Studie: Training des Gedächtnisses und der Psychomotorik im Alter. In: Klauer KJ (Hrsg) Handbuch kognitives Training. Hofgrefe, Göttingen, S 467–490
Owen AM, Doyon J, Dagher A et al (1998) Abnormal basal ganglia out-flow in Parkinson’s disease identified with PET. Brain 121: 949–965
Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer’s disease. J Neural Transm 91: 135–159
Pandav R, Dodge HH, DeKosky ST, Ganguli M (2003) Blood pressure and cognitive impairment in India and the United States. A cross-national epidemiological study. Arch Neurol 60: 1123–1128
Pantel J, Kratz B, Essig M, Schröder J (2003) Parahippocampal volume deficits in subjects with aging-associated cognitive decline. Am J Psychiatry 160: 2
Papapetropoulos S, Gonzalez J, Lieberman A et al (2005) Dementia in Parkinson’s disease: a post-mortem study in a population of brain donors. Int J Geriatr Psychiatry 20: 418–422
Parellada E, Baeza I, de Pablo J, Martinez G (2004) Risperidone in the treatment of patients with delirium. J Clin Psychiatry 65: 348–353
Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely & Jones, London, pp 33–34
Parnetti L, Ambrosoli L, Abate G et al (1995) Posatirelin for the treatment of late-onset Alzheimer’s disease: a double-blind multi-centre study vs citcoline and ascorbic acid. Acta Neurol Scand 92: 135–140
Parvizi J, Damasio AR (2003) Neuroanatomical correlates of brainstem coma. Brain 126: 1524–1536
Patwardhan MB, McCrory DC, Matchar DB et al (2004) Alzheimer disease: operating characteristics of PET — A meta-analysis. Radiology 231: 73–80
Perneczky R, Mösch D, Neumann M et al (2005) The Alzheimer variant of Lewy body disease: A pathologically confirmed case-control study. Dement Geriatr Cogn Disord 20(2–3): 89–94
Perry E, McKeith I, Ballard C et al (2003) Butyrylcholine esterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology 60: 1852–1853
Perry EK, Perry RH (1995) Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 28: 240–258
Perry EK, Marshall E, Kerwin J et al (1990a) Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 55: 1454–1456
Perry RH, Irving D, Blessed G et al (1990b) Senile dementia of Lewy body type. J Neurol Sci 95: 119–139
Perry EK, Morris CM, Court JA et al (1995) Alteration in nicotine binding sites in Parkinson’s disease. Lewy body dementia and Alzheimer’s disease: possible index of early neuropathology. Neuroscience 64: 385–395
Perry RJ, Miller BL (2001) Behavior and treatment in frontotemporal dementia. Neurology 56(Suppl 4): S46–S51
Pezzoli G, Canesi M, Galli C (2004) An overview of parkinsonian syndromes: data from the literature and from an Italian data-base. Sleep Med 5: 181–187
Pick A (1904) Zur Symptomatologie der linksseitigen Schläfenlappenatrophie. Monatsschr Psychiat Neurol 16: 378–388
Plassman BL, Welsh KA, Helms M, Brandt J, Page WF, Breitner JC (1995) Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology 45: 1446–1450
Pohjasvaara T, Mäntylä R, Salonen O et al (2000) How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 57: 1295–1300
Pohjasvaara T, Vataja R, Leppävuori A, Erkinjuntti T (2001) Dementia poststroke. Psychogeriatrics 1: 88–99
Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R (2002) The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58: 1175–1181
Price JL, Ko AI, Wade MJ et al (2001) Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58: 1395–1402
Prins ND, van Dijk EJ, den Heijer T et al (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (in press)
Procter AW, Qurne M, Francis PT (1999) Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord 10: 80–84
PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041
PROGRESS Collaborative Group (2003) Effects of blood pressure lowering with perindopril and indapamide therapy an dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163: 1069875–1075886
Przuntek H, Müller T, Riederer P (2004) Diagnostic staging of Parkinson’s disease: Conceptual aspects. J Neural Transm 111: 201–216
Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L (2003) Low blood pressure and risk of dementia in the Kungsholmen Project. Arch Neurol 60: 223–228
Raadscheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJG, Tilders FJH, Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am J Psychiatry 152: 1372–1376
Rama Krishnan KRR, Charles HC, Doraiswamy PM et al (2003) Randomized, placebo-controlled trial of the effects of Donepezil on neuronal markers and hippocampal volumes in Alzheimer’s disease. Am J Psychiatry 160: 2003–2011
Ramage SN, Anthony IC, Carnie FW, Busutti A, Roberstson R, Bell JE (2005) Hyperphosphorylated tau and amyloid precurson protein deposition is increased in brains of young drug abusers. Neuropathol Appl Neurobiol 31: 439–448
Rankin KP, Kramer JH, Mychack P, Miller BL (2003) Double dissociation of social functioning in frontotemporal dementia. Neurology 60: 266–271
Raskind MA, Peskind ER, Holmes C, Goldstein DS (1999) Patterns of cerebrospinal fluid catechods support increased central noradrenergic responsiveness in aging and Alzheimer’s disease. Biol Psychiatry 46: 756–765
Reischies FM, Neuhaus AH, Hansen ML et al (2005) Electrophysiological and neuropsychological analysis of a delirious state: The role of the anterior cingulate gyrus. Psychiatry Res Neuroimaging 138: 171–181
Remy P, Doder M, Lees AJ et al (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128: 1314–1322
Ribot T (1883) Les maladies de la mémoire, 2ième edn. Baillière, Paris
Riederer P, Hoyer S (2005) Störungen der Neurotransmission bei Demenzen. In: Wallesch CW, Förstl H (Hrsg) Demenzen. Thieme, Stuttgart, S 27–43
Riemenschneider M, Wagenpfeil S, Diehl J et al (2002) Tau and Aß42 protein in CSF of patients with frontotemporal degeneration. Neurology 58: 1622–1628
Rocchi A, Pellegrini S, Siciliano G, Murri L (2003) Causative and susceptibility genes for Alzheimer’s disease: a review. Brain Res Bull 61: 1–24
Rockwood K, Kirkland S, Hogan DB et al (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in communitydwelling elderly people. Arch Neurol 59: 223–227
Román GC, Sachdev P, Royall DR et al (2004) Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226: 81–87
Romero B, Wenz M (2002) Concept and effectiveness of a treatment program for patients with dementia and their relatives. Results from the Bad Aibling Alzheimer Disease Therapy Center. Z Gerontol Geriatr 35: 118–1128
Rosen HJ, Perry RJ, Murphy J et al (2002a) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58: 198–208
Rosen HJ, Gorno-Tempini ML, Goldman WP et al (2002b) Emotion comprehension in the temporal variant of frontotemporal dementia. Brain 125: 2286–2295
Rösler N, Wichart I, Jellinger KA (2001) Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer disease patients. Neurosci Lett 299: 117–120
Rozzini L, Chilovi BV, Bellelli G et al (2005) Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. Int J Geriatr Psychiatry 20: 547–551
Ruitenberg A, van Swieten JC, Witteman JC et al (2002) Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 359: 281–286
Samii A, Nutt JG, Ransom B (2004) Parkinson’s disease. Lancet 363: 1783–1792
Sander D, Kukla C, Klingelhöfer J et al (2000a) Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis. Circulation 102: 1536–1541
Sander D, Winbeck K, Etgen T, Knapp R, Klingelhofer J, Conrad B (2000b) Disturbance of venous flow patterns in patients with transient global amnesia. Lancet 356: 1982–1984
Sander D, Winbeck K, Klingelhöfer J et al (2004) Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 109: 1010–1015
Sander K, Sander D (2005) New insights into transient global amnesia: recent imaging and clinical findings. Lancet 4: 437–444
Sarter M, Bruno JP (1998) Cortical acetylcholine, reality distortion, schizophrenia, and Lewy body dementia: too much or too little cortical acetylcholine? Brain Cogn 38: 297–316
Sasaki Y, Matsuyama T, Inoue S et al (2003) A prospective, open-label, flexible-dose study of Quetiapine in the treatment of delirium. J Clin Psychiatry 64: 1316–1321
Sawabini KA, Watts RL (2004) Treatment of depression in Parkinson’s disease. Parkinsonism Rel Disord 10: S37–S41
Schaafsma A, de Jong BM, Bams JL et al (2003) Cerebral perfusion and metabolism in resucitated patients with severe post-hypoxic encephalopathy. J Neurol Sci 210: 23–30
Scheid R, Voigt H (2005) Arterielle Hypertonie und Demenz. Nervenarzt 76: 143–153
Scheltens P, Fox N, Barkhof F, De Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurology 1: 13–21
Schiff ND, Ribary U, Moreno DR et al (2002) Residual cerebral activity and behavioural fragments can remain in the persistently vegetative brain. Brain 125: 1210–1234
Schillinger M, Exner M, Mlekusch W et al (2005) Inflammation and carotid artery-risk for atherosclerosis study (ICARAS). Circulation 111: 2203–2209
Schmidt R, Schmidt H, Curb JD et al (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52: 168–174
Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F (2003) Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 361: 2046–2048
Schneider K (1946) Klinische Psychopathologie. Thieme, Stuttgart
Schneider F, Habel U, Volkmann J et al (2003a) Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson desease. Arch Gen Psychiatry 60: 296–302
Schneider JA, Wilson RS, Cochran EJ et al (2003b) Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 60: 1082–1083
Schwammenthal Y, Tanne D (2004) Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurology 3: 493–495
Sedlaczek O, Hirsch JG, Grips E, et al (2004) Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology 62: 2165–2170
Selkoe DJ (2000) The genetics and molecular pathology of Alzheimer’s disease: roles of amyloid and the presenilins. Neurol Clin 18(4): 903–922
Selkoe DJ (2004) Alzheimer disease: Mechanistic unerstanding pedicts novel therapies. Ann Intern Med 140: 627–638
Semon R (1904) Die Mneme. Engelmann, Leipzig, S 20–21
Senanarong V, Vannasaeng S, Poungvarin N et al (2002) Endogenous estradiol in elderly individuals. Arch Neurol 59: 385–389
Sergeant N, Delacourte A, Buée L (2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739: 179–197
Seshadri S, Beiser A, Selhub J et al (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346: 476–483
SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Ass 265: 3255–3264
Shepherd J, Blauw GJ, Murphy MB et al; PROSPER Study Group (2002) PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360: 1623–1630
Shigenobu K, Ikeda M, Fukuhara R (2002) The stereotypy rating inventory for frontotemporal lobar degeneration. Psychiatry Res 110: 175–187
Shumaker SA, Logault C, Rapp SR et al (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women’s Health Initiative Memory Study: a randomised controlled trial. J Am Med Ass 289: 2651–2662
Silveri MC, Salvigni BL, Cappa A et al (2003) Impairment of verb processing in frontal variant-frontotemporal dementia: a dysexecutive symptom. Dement Geriatr Cogn Disord 16: 296–300
Simons M, Keller P, Strooper B et al (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95: 6460–6464
Simons M, Schwarzler F, Lutjohann D et al (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52(3): 346–350
Skoog I, Lernfelt B, Landahl S et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141–1145
Small SA, Tsai WY, DeLaPaz R et al (2002) Imaging hippocampal function across the human life span: Is memory decline normal or not? Ann Neurol 51: 290–295
Snowden JS, Bathgate D, Varma A et al (2001) Distinct behavioural profiles in fronto-temporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 70: 323–332
Snowden JS, Gibbons ZC, Blackshaw A et al (2003) Social cognition in frontotemporal dementia and Huntington’s disease. Neuropsychologia 41: 688–701
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease — the nun study. J Am Med Ass 277: 813–817
Sparks DL, Sabbagh MN, Connor DJ et al (2005) Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62:753–757
Spector A, Orrell M, Davies S et al (2000a) Reminiscence therapy for dementia. Cochrane Database Syst Rev CD001120
Spector A, Orrell M, Davies S et al (2000b) Reality orientation for dementia. Cochrane Database Syst Rev CD001119
St George-Hyslop PH, Tanzi RE, Polinski RJ et al (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235: 885–890
Stevens M, Van-Duijn CM, Kamphorst W et al (1998) Familial aggregation in frontotemporal dementia. Neurology 50: 1541–1545
Stone J, Griffiths TD, Rastogi S, Perry RH, Cleland PG (2002) Non-Picks forntotemporal dementia imitating schizophrenia in a 22-year-old man. J Neurol 250: 369–370
Stoub TR, Bulgakova M, Leurgans S et al (2005) MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 64(9): 1520–1524
Summerfield C, Gómez-Ansón B, Tolosa E et al (2002) Dementia in Parkinson desease. Arch Neurol 59: 1415–1420
Sumpter PQ, Mann DM, Davies CA, Neary D, Snowden JS, Yates PO (1986) A quantitative study of the ultrastructure of pyramidal neurons of the cerebral cortex in Alzheimer’s disease in relationship to the degree of dementia. Neuropathol Appl Neurobiol 12: 321–329
Sze C, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ (2001) NMethyl-D-aspartate receptor submit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease. J Neurol Sci 182: 151–159
Tabert MH, Albert SM, Borukhova-Milov L et al (2002) Functional deficits in patients with mild cognitive impairment. Neurology 58: 758–764
Tanzi RE, Gusella JF, Watkins PC et al (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880–884
Tariot PN, Farlow MR, Grossberg GT et al (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. J Am Med Assoc 291: 317–324
Teipel SJ, Flatz WH, Heinsen H et al (2005) Measurement of basal forebrain atrophy in Alzheimer’s disease using MRI. Brain (in press)
Tellez S, Colpaert F, Marien M (1999) α2-Adrenoreceptor modulation of cortical acetylcholine release in vivo. Neuroscience 89: 1041–1050
Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aß-deposition in the human brain and its relevance for the development of AD. Neurology 58: 1791–1800
Thomas AJ, O’Brien JT, Davis S et al (2002) Ischemic basis for deep white matter hyperintensities in Major Depression. Arch Gen Psychiatry 59: 785–792
Thomas AJ, Kalaria RN, O’Brien JT (2004) Depression and vascular disease: what is the relationship? J Affect Disord 79: 81–95
Tierney MC, Black SE, Szalai JP et al (2001) Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 58: 1654–1659
Tiraboschi P, Hansen LA, Alford M et al (2000) The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease. Neurology 55:1278–1283
Tiraboschi P, Hansen LA, Alford M et al (2002) Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry 59: 946–951
Tong XK, Hamel E (1999) Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer’s disease. Neuroscience 92: 163–175
Truelsen T, Thudium D, Gronbaek M (2002) Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 59: 1313–1319
Trzepacz PT(1999) Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord 10: 330–334
Trzepacz PT (2000) Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5: 132–148
Tsai GE, Falk WE, Gunther J, Coyle JT (1999) Improved cognition in Alzheimer’s disease with short-term D-cycloserine treatment. Am J Psychiatry 156: 467–469
Tulving E (1985) How many memory systems are there? Psychologist 60: 385–398
Tulving E (2002) Episodic memory: From mind to brain. Annu Rev Psychol 53: 1–25
Tuokko H, Morris C, Ebert P (2005) Mild cognitive impairment and everyday functioning in older adults. Neurocase 11(1): 40–47
Turner RS, D’Amato CJ, Chervin RD et al (2000) The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 55: 1730–1732
Uzan M, Albayram S, Dashti SGR et al (2003) Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury. J Neurol Neurosurg Psychiatry 74: 33–38
van der Hart O, Nijenhuis E (2001) Generalized dissociative amnesia: episodic, semantic and procedural memories lost and found. Aust N Z J Psychiatry 35: 589–600
van Duijn CM, Farrer LA, Cupples LA, Hofman A (1993) Genetic transmission of Alzheimer’s disease among families in a Dutch population-based study of early-onset Alzheimer’s disease. Nature Genet 7: 74–78
Verleger R, Koempf D, Neukaeter W (1992) Event-related EEG potentials in mild dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol 84: 332–343
Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM, Rotterdam Scan Study (2003) Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34: 1126–1129
Verpillat P, Camuzat A, Hannequin D et al (2002) Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 10: 399–405
Versijpt J, Van Laere KJ, Dumont F et al (2003) Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings. Neurobiol Aging 24: 553–561
Visser PJ, Verhey FRJ, Hofman PAM et al (2002) Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72: 491–497
Waelti P, Dickinson A, Schultz W (2001) Dopamine responses comply with basic assumptions of formal learning theory. Nature 412: 43–48
Waite LM, Broe GA, Grayson DA, Creasey H (2001) Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry 71: 296–302
Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L (2001) Vitamin B12 and folate in relation to the development of Alzheimer’s disease. Neurology 56: 1188–1194
Weggen S, Eriksen JL, Das P et al (2001) A subset of NSAIDs lower amyloidogenic A-42 independently of cyclooxygenase activity. Nature 414: 212–216
Wei Z, Mousseau DD, Richardson JS, Dyck LE, Li X-M (2003) Atypical antipsychotics attenuate neurotoxicity of Beta-Amyloid (25–35) by modulating bax and Bcl-XL/S expression and localization. J Neurosci Res 74: 942–947
Wijdicks EFM, Atkinson JLD, Okazaki H (2001) Isolated medulla oblongata function after severe traumatic brain injury. J Neurol Neurosurg Psychiatry 70: 127–129
Wilkie F, Eisdorfer C (1971) Intelligence and blood pressure in the aged. Science 172: 959–962
Winbeck K, Etgen T, von Einsiedel HG, Rottinger M, Sander D (2005) DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. J Neurol Neurosurg Psychiatry 76: 438–441
Yaffe K, Lui LY, Grady D, Cauley, J, Kramer J, Cummings SR (2000) Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 356: 708–712
Yamaguchi S, Tsuchiya H, Yamagata S, Toyoda G, Kobayski S (2000) Event-related brain potentials in response to novel sounds in dementia. Clin Neurophysiol 111: 195–203
Yasui K, Nakaso K, Kowa H et al (2003) Levodopa-induced hyperhomocysteinaemia in Parkinson’s disease. Acta Neurol Scand 108: 66–67
Yokota H, Ogawa S, Kurokawa A, Yamamoto Y (2003) Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci 57: 337–339
Zandi PP, Anthony JC, Khachaturian AS et al (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 61: 82–88
Zeman A (2001) Consciousness. Brain 124: 1263–1289
Zhou L, Miller BL, McDaniel CH et al (1998) Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration. Ann Neurol 44: 99–109
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Förstl, H. (2006). Kognitive Störungen: Koma, Delir, Demenz. In: Förstl, H., Hautzinger, M., Roth, G. (eds) Neurobiologie psychischer Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30887-3_5
Download citation
DOI: https://doi.org/10.1007/3-540-30887-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25694-6
Online ISBN: 978-3-540-30887-4
eBook Packages: Medicine (German Language)